An independent guide to cash-pay care. Every price is dated and sourced.

How we check

Zepbound: doses, cost and how to get it

Zepbound (tirzepatide) is FDA-approved for long-term weight management and for obstructive sleep apnea in adults with obesity, and its label spells out the risks: a boxed warning for thyroid tumors seen in rats, plus pancreatitis, gallbladder disease and kidney injury from dehydration, among others [1][2]. In its weight trials, 4.8% to 6.7% of people stopped because of side effects, compared with 3.4% on placebo [2].

Medical review: pending. A licensed clinician has not yet reviewed this page.

Zepbound is Eli Lilly's brand of tirzepatide, a once-weekly GIP and GLP-1 receptor agonist injection approved for chronic weight management and obstructive sleep apnea in adults with obesity.

Active ingredient
Tirzepatide, the same drug as Mounjaro [3]
Approved
Nov 8, 2023 for weight [4]; Dec 20, 2024 for sleep apnea [5]
Who qualifies (weight)
Adults with BMI 30 or more, or 27 or more with a weight-related condition [4]
Average loss in trial
20.9% at 72 weeks on 15 mg vs 3.1% on placebo [2]
Self-pay
$299 to $449 a month, vial or KwikPen, on LillyDirect (Oct 17, 2026) [6]

What Zepbound is

Zepbound contains tirzepatide, a GIP receptor and GLP-1 receptor agonist made by Eli Lilly [2]. So yes, it is a GLP-1 medicine, and it also acts on a second hormone receptor, GIP. It is not semaglutide, the drug in Wegovy and Ozempic, and it is not insulin. It is a brand product, not a compounded one; compounded tirzepatide is a different, unapproved product (see compounded tirzepatide).

Is Zepbound the same as Mounjaro? Same molecule, different labels. Mounjaro is approved for type 2 diabetes; Zepbound for weight and sleep apnea. Lilly says Zepbound should not be used with other tirzepatide products [3]. Full comparison: Mounjaro vs Zepbound. Drug background: tirzepatide.

What Zepbound is approved to treat

  • Weight. With a reduced-calorie diet and more activity, to reduce excess weight and keep it off in adults with obesity, or overweight with at least one weight-related condition [1]. FDA described this as a BMI of 30 or more, or 27 or more with at least one weight-related condition [4].
  • Obstructive sleep apnea. Moderate to severe sleep apnea in adults with obesity. FDA called it the first drug for certain patients with the condition [5]. In the two label trials, breathing interruptions fell by 25.3 and 29.3 events per hour, vs about 5 on placebo [2].

How Zepbound works

The label says tirzepatide lowers calorie intake, likely through appetite, and slows stomach emptying, most after the first dose [2]. Does Zepbound burn fat? It works by eating less, not by burning fat directly; the label notes weight loss on tirzepatide includes more fat than lean mass [2]. More in how GLP-1 medicines work.

Pens, vials and the KwikPen

Zepbound forms
FormDosesNotes
Single-dose pen2.5, 5, 7.5, 10, 12.5 or 15 mg per 0.5 mLOne shot, then discard [1]
Single-dose vialSame strengthsNeeds a syringe that measures 0.5 mL; new syringe and needle each time [1]
KwikPen (multi-dose)4 doses per pen, 2.5 to 15 mg per doseLaunched Feb 23, 2026 [7]; pen needles sold separately [6]; never share a pen [1]
There is no Zepbound pill. The label lists only injections [1]. Lilly's pill, Foundayo, is a different drug.

Doses and when to take it

Everyone starts at 2.5 mg once a week for 4 weeks, a starting dose only. Then 5 mg, with 2.5 mg increases after at least 4 weeks on each dose. Maintenance is 5, 10 or 15 mg for weight and 10 or 15 mg for sleep apnea; 15 mg is the maximum [1]. Take it any day and time, with or without food, as long as doses stay at least 72 hours apart; a missed dose can be taken within 4 days [1]. Details: Zepbound dosage and how to use tirzepatide.

How safe is Zepbound?

Side effects in Zepbound weight trials (percent of people)
Side effectPlacebo5 mg10 mg15 mg
Nausea8252928
Diarrhea8192123
Vomiting281113
Constipation5171411
Injection site reactions2688
Hair loss1545
Zepbound label, Section 6.1 [2]. More: Zepbound side effects.

The boxed warning covers thyroid C-cell tumors in rats; whether this happens in humans is unknown. Zepbound is not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2 [2]. Other warnings: severe stomach reactions (not recommended in severe gastroparesis), kidney injury from fluid loss, gallbladder disease, pancreatitis, allergic reactions, diabetic eye complications, and aspiration during anesthesia [2][1]. In February 2026 the suicidal thoughts warning was removed from the label [1].

Can Zepbound cause low blood sugar?

Rarely without diabetes drugs. In the trial of adults without diabetes, 0.3% had blood sugar below 54 mg/dL vs 0% on placebo. In adults with type 2 diabetes it was 4.2% vs 1.3%, rising to 10.3% for people also taking a sulfonylurea [2]. Is Zepbound good for diabetics? It is labeled for weight, not blood sugar; in that diabetes trial, average weight loss was 12.8% to 14.7% [2]. The diabetes-labeled version is Mounjaro.

Pregnancy, birth control and other medicines

"Weight loss offers no benefit to a pregnant patient and may cause fetal harm," so Zepbound is stopped when pregnancy is recognized [2]. Birth control pills may work less well: use a non-oral method or add a barrier method for 4 weeks after starting and after each dose increase [8]. See Zepbound interactions.

Call your clinician or 911

Stop Zepbound and get care for severe stomach pain that will not go away (possible pancreatitis) [2]. Get emergency help for swelling of the face, lips or throat or trouble breathing. Report a neck lump, trouble swallowing or lasting hoarseness. Tell your surgical team you take it before any procedure with anesthesia [2].

Results

In the main weight trial, average loss at 72 weeks was 15.0% on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg, vs 3.1% on placebo [2]. In SURMOUNT-4, people who switched to placebo after 36 weeks regained 14.0% of body weight by week 88 [9]. Read Zepbound results and what happens when you stop.

What Zepbound costs

Zepbound prices, checked October 17, 2026
RoutePrice per monthConditionsSource
LillyDirect self-pay, vial or KwikPen$299 (2.5 mg), $399 (5 mg), $449 (7.5 to 15 mg)$449 tier needs a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10 to 15 mg)[6]
Savings card, plan covers ZepboundAs little as $25Commercial insurance only; card ends Dec 31, 2026[10]
Savings card, plan does not cover$499 (single-dose pen); $299 to $449 (KwikPen)Commercial insurance only[10]
Medicare GLP-1 Bridge$50 copayKwikPen only; eligible Part D enrollees[11][12]
TrumpRxFrom $299Routes to LillyDirect; listed original price $1,087[13]
More: Zepbound cost and Zepbound insurance coverage.

How to get Zepbound

  1. Get a prescription from a licensed clinician, in person or online. See tirzepatide near you or online GLP-1 programs.
  2. With insurance, ask about prior authorization; Lilly says select CVS Caremark formularies cover Zepbound from $25 a month [3].
  3. Self-pay: your prescriber sends the prescription to LillyDirect Pharmacy, a partner pharmacy confirms details, and you choose free home delivery or Walmart Pharmacy pickup [6].

All Zepbound guides

In this section

Costs and prices

Guides

Questions people ask

Is Zepbound safe?

It is FDA-approved with known risks. The label has a boxed warning for thyroid C-cell tumors in rats and warnings for pancreatitis, gallbladder disease, kidney injury and others. In trials, 4.8% to 6.7% stopped due to side effects vs 3.4% on placebo [2].

What is Zepbound used for?

Chronic weight management in adults with obesity, or overweight with a weight-related condition, and moderate to severe obstructive sleep apnea in adults with obesity [1].

Is Zepbound a GLP-1?

Yes. Its ingredient, tirzepatide, is a GIP receptor and GLP-1 receptor agonist, so it acts on both hormone receptors [2].

Who makes Zepbound?

Eli Lilly and Company makes Zepbound and also sells it direct through LillyDirect [1][6].

What BMI qualifies for Zepbound?

For weight management, FDA described eligible adults as having a BMI of 30 or more, or 27 or more with at least one weight-related condition [4]. Your prescriber makes the call.

Does Zepbound come in pill form?

No. The Zepbound label lists only injectable forms: single-dose pens and vials, and a multi-dose KwikPen [1]. Lilly's pill, Foundayo, contains orforglipron, a different drug [14].

When did Zepbound come out?

FDA approved Zepbound for chronic weight management on November 8, 2023 [4], and for obstructive sleep apnea on December 20, 2024 [5].

Can Zepbound cause low blood sugar?

In adults without diabetes it was rare: 0.3% vs 0% on placebo. In adults with type 2 diabetes it was 4.2% vs 1.3%, and 10.3% among those also on a sulfonylurea [2].

How much is Zepbound without insurance?

On LillyDirect, $299 a month for 2.5 mg, $399 for 5 mg and $449 for 7.5 to 15 mg with refills inside 45 days, checked October 17, 2026 [6].

Sources

14 cited
  1. Zepbound (tirzepatide) injection prescribing information. DailyMed, National Library of Medicine (Eli Lilly label), Aug 2026.
  2. Zepbound prescribing information, 217806 s050. US Food and Drug Administration, Apr 2026.
  3. Zepbound frequently asked questions. Eli Lilly and Company, Oct 17, 2026.
  4. FDA approves new medication for chronic weight management. US Food and Drug Administration, Nov 8, 2023.
  5. FDA approves first medication for obstructive sleep apnea. US Food and Drug Administration, Dec 20, 2024.
  6. Zepbound on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
  7. Zepbound now available in multi-dose KwikPen. Eli Lilly and Company via PR Newswire, Feb 23, 2026.
  8. Mounjaro (tirzepatide) injection prescribing information. DailyMed, National Library of Medicine (Eli Lilly label), Aug 2026.
  9. Continued treatment with tirzepatide for maintenance of weight reduction (SURMOUNT-4). JAMA (PubMed record), Jan 1, 2024.
  10. Zepbound coverage and savings. Eli Lilly and Company, Oct 17, 2026.
  11. Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare and Medicaid Services, Oct 17, 2026.
  12. Weight loss drugs coverage. Medicare.gov, Oct 17, 2026.
  13. TrumpRx.gov. US government, Oct 17, 2026.
  14. Foundayo (orforglipron) prescribing information. Eli Lilly and Company (FDA-approved labeling), Jul 2026.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

See Zepbound prices by dose